For two decades, search operated on a simple premise: brands competed for page-one placement because algorithms determined what users saw.  

Google’s May 2026 AI Search update has rewritten that premise. AI Overview now pulls blogs, forums, social posts, patient perspectives, caregiver voices, and key opinion leader (KOL) commentaries as equally weighted inputs to how medical questions get answered. Attribution and authenticity are becoming the organizing principles. Human voices are becoming the raw material for how categories are explained. 

For healthcare and pharma, this is a strategic crisis you have not yet felt. 

When patients ask Google a medical question in AI mode, the system builds the answer from voices it deems credible and authentic. If your medically sound, attributed voices are not present in that ecosystem, less accurate or competitor-favorable voices will be. You will not control that narrative; you will discover it after it has already been written. 

You cannot win by building the most sophisticated brand website or disease education hub. The new layer of discovery is being constructed in conversations patients are already having, in voices patients already trust, in spaces your brand has not yet thought to occupy. 

Google is signaling something specific: in an AI search environment, loyalty and familiarity determine which sources users trust. Brands that cultivate credible, human voices in blogs, forums, and expert partnerships will have those voices amplified. Brands that outsourced credibility to anonymous disease education will be deprioritized. 

The mandate is no longer search engine optimization, it is voice strategy. Pharma content strategy must expand beyond polished brand pages to include KOLs and digital opinion leaders, authored explainers, patient advocate partnerships, caregiver perspectives, and community-informed content with named medical reviewers. This is not campaign work, it is ongoing, trust-building work. It is showing up as a credible participant in conversations that matter. 

What Might Be Around the Corner? 

Expect AI Overview to become the primary narrative layer for entire categories. Regulatory bodies will demand new standards for how clinical claims are presented so AI systems can evaluate them accurately. The distinction between marketing content and patient education will blur. Everything will be conversational, attributed, and subject to how AI systems assess trust. The window to build those credible voices is narrow. Once the narrative is written, it will be difficult to rewrite.